Allcare

Qingdao Allcare Biomedical Development Co Ltd (Allcare Biomedical) is a clinical-stage biotechnology company based in Qingdao, China, specializing in the research, development, and preservation of stem cell therapies. Founded in 2003, the company focuses on human umbilical cord-derived mesenchymal stem cells (UC-MSCs) for the treatment of inflammatory and degenerative diseases. Its lead clinical program, a human umbilical cord mesenchymal stem cell injection, is currently in Phase 2 clinical trials for moderate-to-severe ulcerative colitis and is also being evaluated for dilated cardiomyopathy. Allcare Biomedical operates a large-scale regenerative medicine and cell preparation facility, including the Shandong Human Umbilical Cord Mesenchymal Stem Cell Bank, in collaboration with the Affiliated Hospital of Qingdao University.